NEW YORK, March 2 (GenomeWeb News) - Spectral Genomics of Houston, Texas, said yesterday that it has agreed to license certain Affymetrix patents to manufacture and sell spotted DNA arrays for use in the diagnostics market.

The agreement will commence "once the necessary regulatory approvals of Spectral Genomics' products have been obtained," the company said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.